PNC Financial Services Group’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-2,000
Closed -$9K 4029
2016
Q2
$9K Sell
2,000
-1,042
-34% -$4.77K ﹤0.01% 3593
2016
Q1
$14K Hold
3,042
﹤0.01% 3422
2015
Q4
$16K Hold
3,042
﹤0.01% 3395
2015
Q3
$18K Hold
3,042
﹤0.01% 3415
2015
Q2
$22K Buy
3,042
+42
+1% +$292 ﹤0.01% 3459
2015
Q1
$20K Hold
3,000
﹤0.01% 3503
2014
Q4
$18K Buy
3,000
+2,000
+200% +$10.3K ﹤0.01% 3179
2014
Q3
$5K Hold
1,000
﹤0.01% 3447
2014
Q2
$5K Hold
1,000
﹤0.01% 3305
2014
Q1
$5K Sell
1,000
-600
-38% -$2.85K ﹤0.01% 3236
2013
Q4
$8K Sell
1,600
-2,323
-59% -$11.3K ﹤0.01% 3037
2013
Q3
$19K Hold
3,923
﹤0.01% 2862
2013
Q2
$20K Buy
+3,923
New +$19.5K ﹤0.01% 2739

Other funds holding CPIX

PNC Financial Services Group's CPIX Position: Q3 2016 in Review

PNC Financial Services Group sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2016, closing a stake of 2,000 shares — an estimated $9K sold.

PNC Financial Services Group first reported a position in CPIX in Q2 2013 and held it in 13 quarters. The position peaked at $22K in Q2 2015. 40 funds tracked by Wall St. Rank hold CPIX as of Q3 2016.

  • PNC Financial Services Group reported no remaining Cumberland Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 2,000 Cumberland Pharmaceuticals shares in Q3 2016, an estimated $9K.
  • PNC Financial Services Group first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • PNC Financial Services Group's Cumberland Pharmaceuticals position peaked at $22K in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.